World News
Drug Cuts Albuminuria in Type 1 Diabetic Kidney Disease, Too

https://www.profitableratecpm.com/f4ffsdxe?key=39b1ebce72f3758345b2155c98e6709c
(MedPage Today) — Finerenone (Kerendia) significantly reduced albuminuria in adults with type 1 diabetes and chronic kidney disease (CKD), meeting the primary endpoint of the phase III FINE-ONE trial.
Over 6 months, the urinary albumin-to-creatinine…


